A resident with dementia and major depressive disorder received PRN Ativan without a stop date, and the MAR and nursing notes lacked documentation of the reason for use or non-pharmacological interventions before administration. Staff observed the resident walking the unit, and interviews showed the resident was usually redirectable, while the family member said the medication was presented as the only way staff could manage the resident’s walking.
The facility failed to properly document and monitor psychotropic medication use for two residents. One resident with dementia and hospice care had PRN lorazepam ordered without the required 14-day stop date or documented duration for continued use beyond 14 days, and the record showed only intermittent administration. Another resident with dementia and behavioral disturbance received routine antipsychotic medications, but the chart lacked specific target behaviors and routine behavior monitoring documentation, and staff were unsure what behaviors were being tracked.
A resident with anxiety and depression, and a BIMS score of 14/15, was observed upset and speaking loudly about a breakfast tray while receiving alprazolam 0.5 mg PRN for anxiety. The order had no documented stop date, duration, or clinical rationale in the chart, and the DON stated PRN psychoactive meds should have a defined duration and documentation in the record.
A resident with respiratory failure, ventilator dependence, Alzheimer's disease, and major depression was receiving Seroquel plus multiple antidepressants for reported past combativeness, spitting, and restlessness. Staff observations and charting showed the resident was calm, nonverbal, and had no documented aggressive behaviors or refusal of care, while monthly psychotropic reviews repeatedly showed zero target behaviors and no documented nonpharmacologic interventions. The NP stated the meds were for prior behaviors but had not reviewed the monthly psychotropic evaluations.
A resident with anorexia and dementia, and a BIMS score of 00, had a PRN lorazepam order for anxiety that was not limited to 14 days and lacked documented rationale for extension. Staff gave conflicting statements about whether the order was to be reevaluated, renewed, or extended, while the facility policy stated PRN anxiolytics are for 14 days and then reviewed by the MD.
A resident with generalized anxiety disorder and unspecified dementia was observed walking the halls and speaking incoherently to themselves. The resident had a BIMS score of 1/15, and an order for Lorazepam PRN for anxiety was written for 90 days without documented clinical rationale in the EMR. The DON stated the physician’s assessment should indicate the need for the extended duration, and the facility policy limited PRN psychotropic orders to 14 days unless the prescriber documented the reason for extension.
A resident with COPD, muscle weakness, difficulty walking, and need for assistance with personal care had orders for duloxetine for depression, trazodone for insomnia, and PRN clonazepam for insomnia/anxiety. The chart lacked documented behavior monitoring for the psychotropic meds, the cMDS did not identify an active diagnosis for the antianxiety and antidepressant meds, and the record did not clearly document an indication for insomnia. The LPN/UM confirmed behavior monitoring should be in the eMAR, and the DON stated the clonazepam order and behavior monitoring were clarified after the surveyor’s inquiry.
Inadequate monitoring and inappropriate diagnosis for antipsychotic use: A resident with severe cognitive impairment and dementia-related behaviors received quetiapine and divalproex, but the MDS did not show an active diagnosis for the antipsychotic, the care plan did not list target behaviors, and behavior monitoring was not documented when the antipsychotic was started or increased. The psych APRN described restlessness in the evenings without aggression or psychotic symptoms, while the LPN, UM, and DON stated that target behaviors and monitoring should be documented and that restlessness and agitation were not appropriate diagnoses for the antipsychotic.
Failure to follow up on a psychiatrist’s recommended GDR for quetiapine. A resident with major depressive disorder, PTSD, and paranoid schizophrenia was receiving antipsychotic medication, and the psych note recommended reducing Seroquel from 50 mg HS to 25 mg HS for 7 days, then discontinuing it. The MAR showed the medication continued as ordered, but the chart lacked documentation that the PCP or resident representative addressed the recommendation, and the consultant pharmacist also noted the need for follow-up.
Missing monitoring orders for psychotropic medication: A resident with depression, psychotic disturbance, and anxiety was receiving an antidepressant and an antipsychotic, but the chart lacked physician orders to monitor behaviors and potential side effects. The RN stated such monitoring should be ordered for residents on psychiatric meds, and the DON acknowledged the orders were missing after the resident returned from acute care.
Self-audit
Pick a level of detail and, optionally, what to focus on — then generate a survey-ready checklist distilled from the most recent citations.
Beta · AI-generated — for reference only, not professional advice. Verify against current CMS guidance before relying on it. Assisto accepts no responsibility for how this checklist is used.
Citations used to create this checklist
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release October 8, 2026) and official state health department websites — never guesswork.
In your survey window? See what surveyors are citing.
The Survey-Prep Report maps your facility's risk from 12 months of CMS and state citation data — what's being cited around you and what to check first. $129 one-time.